Google DeepMind announced AlphaProtein Novo, a generative model that designs enzymes from scratch, with one custom enzyme synthesizing piperidine 99 times faster than the current industrial process, a…
Google DeepMind released AlphaGenome Atlas, a free research database with AI-generated predictions for the effects of all 9 billion possible single-letter mutations in the human genome, built from its…
Google DeepMind unveiled AlphaGenome Atlas, an AI-powered platform that predicts the molecular effects of all nine billion possible single-letter DNA changes in the human genome, aiming to help resear…
Google DeepMind has released AlphaGenome Atlas, an AI-powered database predicting the biological effects of all 9 billion possible single-point mutations in the human genome, available free to academi…
Arm Holdings CEO Rene Haas said AI will find a cure for cancer within the next few decades by solving problems too complex for humans, such as modelling DNA markers impacted by cancer. Haas told the B…
Anthropic, OpenAI, and Google DeepMind have jointly announced a suite of safety measures for AI-powered biology tools, including real-time content classifiers, vetted researcher access, and red teamin…
AI companies including Anthropic, Nvidia, and Google's Isomorphic Labs are increasingly investing in health care and drug discovery to counter public backlash over data centers and job losses, with Nv…
Insilico Medicine named five humans, including CEO Alex Zhavoronkov, as inventors on a patent for a pulmonary fibrosis drug that its generative AI platform proposed, highlighting a US legal rule that …
Vivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has built HIVE, modular robotic labs that grow 20 kinds of human tissue and autonomously dose and monitor them, aiming t…
AI-driven drug discovery has attracted US$60 billion since 2019, with 175 AI-originated programmes entering human trials, yet none have won FDA approval; however, AI-discovered molecules clear Phase I…
Demis Hassabis, co-founder of Google DeepMind, will become chief scientist at Alphabet, succeeding Jeff Dean, who is leaving for a start-up. Hassabis will focus on artificial general intelligence (AGI…
DeepMind CEO Demis Hassabis is stepping aside from day-to-day leadership to become chair of DeepMind and chief scientist at Alphabet, with Koray Kavukcuoglu taking over as senior vice president report…
Google and Alphabet CEO Sundar Pichai announced that Demis Hassabis will become Chair of Google DeepMind and Chief Scientist of Alphabet, while Koray Kavukcuoglu will step up as SVP of Google DeepMind…
Google DeepMind has disbanded the dedicated research team behind AlphaFold, the Nobel Prize-winning protein-structure prediction system, according to a Financial Times report. Nobel laureate John Jump…
Google has dismantled the original AlphaFold team, reassigning many researchers to Gemini and Isomorphic Labs, while several key members including Nobel laureate John Jumper left for Anthropic, accord…
Google DeepMind dissolved the team that built AlphaFold, but the AlphaFold Protein Structure Database remains operational and is hosted by EMBL-EBI, not Google, with no deprecation or sunset date. The…
Google DeepMind has dismantled the team behind its Nobel Prize-winning AlphaFold protein-folding AI, reassigning most original authors and losing nearly a quarter of them, including Nobel co-winner Jo…
Google DeepMind has disbanded its Nobel Prize-winning AlphaFold team, with roughly 25% of the original research authors departing the company, including Nobel laureate John Jumper who joined Anthropic…
Google Deepmind has dismantled the team behind its Nobel Prize-winning AlphaFold protein-folding AI, reassigning most original authors to projects involving Gemini, enzyme design, nuclear fusion, and …
Google DeepMind has disbanded its Nobel Prize-winning AlphaFold team, with about a quarter of researchers leaving the company, including lead John Jumper who joined Anthropic in June 2026. The Financi…